The TGF-β superfamily cytokine MIC-1/GDF15: Secretory mechanisms facilitate creation of latent stromal stores

Journal of Interferon and Cytokine Research

Volumn 30, Issue 6, 2010, Pages 389-397

  Bauskin, Asne R ^a   Jiang, Lele ^a   Luo, X Wei ^a   Wu, Liyun ^a   Brown, David A ^a   Breit, Samuel N ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH DIFFERENTIATION FACTOR 15; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CELL STRAIN U937; CYTOKINE RELEASE; ENDOPLASMIC RETICULUM; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN LOCALIZATION; STROMA CELL; TRANS GOLGI NETWORK;

ARTHRITIS, RHEUMATOID; ATHEROSCLEROSIS; CELL DIFFERENTIATION; CELL HYPOXIA; CLONING, MOLECULAR; COBALT; GROWTH DIFFERENTIATION FACTOR 15; HUMANS; IMMUNIZATION; LIPOPOLYSACCHARIDES; MACROPHAGES; NEOPLASMS; PROTEIN PROCESSING, POST-TRANSLATIONAL; SECRETORY PATHWAY; TRANSFORMING GROWTH FACTOR BETA; TRANSGENES; TRETINOIN; U937 CELLS;

EID: 77953590551     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.2009.0052     Document Type: Article

References (58)

1. Albertoni M, Shaw PH, Nozaki M, Godard S, Tenan M, Hamou MF, Fairlie DW, Breit SN, Paralkar VM, de Tribolet N, Van Meir EG, Hegi ME. 2002. Anoxia induces macrophage inhibitory cytokine-1 (MIC-1) in glioblastoma cells independently of p53 and HIF-1. Oncogene 21 ( 27 ): 4212-4219.
2. Allavena P, Garlanda C, Borrello MG, Sica A, Mantovani A. 2008. Pathways connecting infl ammation and cancer. Curr Opin Genet Dev 18 ( 1 ): 3-10.
3. Baek SJ, Kim JS, Nixon JB, DiAugustine RP, Eling TE. 2004. Expression of NAG-1, a transforming growth factor-beta superfamily member, by troglitazone requires the early growth response gene EGR-1. J Biol Chem 279 ( 8 ): 6883-6892.
4. Baek SJ, Kim KS, Nixon JB, Wilson LC, Eling TE. 2001. Cyclooxygenase inhibitors regulate the expression of a TGF-beta superfamily member that has proapoptotic and antitumorigenic activities. Mol Pharmacol 59 ( 4 ): 901-908.
5. Bauskin AR, Brown DA, Junankar S, Rasiah KK, Eggleton S, Hunter M, Liu T, Smith D, Kuffner T, Pankhurst GJ, Johnen H, Russell PJ, Barret W, Stricker PD, Grygiel JJ, Kench JG, Henshall SM, Sutherland RL, Breit SN. 2005. The propeptide mediates formation of stromal stores of PROMIC-1: role in determining prostate cancer outcome. Cancer Res 65 ( 6 ): 2330-2336.
6. Bauskin AR, Brown DA, Kuffner T, Johnen H, Luo XW, Hunter M, Breit SN. 2006. Role of macrophage inhibitory cytokine-1 in tumorigenesis and diagnosis of cancer. Cancer Res 66 ( 10 ): 4983-4986.
7. Bauskin AR, Zhang HP, Fairlie WD, He XY, Russell PK, Moore AG, Brown DA, Stanley KK, Breit SN. 2000. The propeptide of macrophage inhibitory cytokine (MIC-1), a TGF-beta superfamily member, acts as a quality control determinant for correctly folded MIC-1. EMBO J 19 ( 10 ): 2212-2220.
8. Blázquez M, Shennan KI. 2000. Basic mechanisms of secretion: sorting into the regulated secretory pathway. Biochem Cell Biol 78 ( 3 ): 181-191.
9. Bootcov MR, Bauskin AR, Valenzuela SM, Moore AG, Bansal M, He XY, Zhang HP, Donnellan M, Mahler S, Pryor K, Walsh BJ, Nicholson RC, Fairlie WD, Por SB, Robbins JM, Breit SN. 1997. MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily. Proc Natl Acad Sci USA 94 ( 21 ): 11514-11519.
10. Brown DA, Breit SN, Buring J, Fairlie WD, Bauskin AR, Liu T, Ridker PM. 2002. Concentration in plasma of macrophage inhibitory cytokine-1 and risk of cardiovascular events in women: a nested case-control study. Lancet 359 ( 9324 ): 2159-2163.
11. Brown DA, Moore J, Johnen H, Smeets TJ, Bauskin AR, Kuffner T, Weedon H, Milliken ST, Tak PP, Smith MD, Breit SN. 2007. Serum macrophage inhibitory cytokine 1 in rheumatoid arthritis: a potential marker of erosive joint destruction. Arthritis Rheum 56 ( 3 ): 753-764.
12. Brown DA, Stephan C, Ward RL, Law M, Hunter M, Bauskin AR, Amin J, Jung K, Diamandis EP, Hampton GM, Russell PJ, Giles GG, Breit SN. 2006. Measurement of serum levels of macrophage inhibitory cytokine 1 combined with prostate-specifi c antigen improves prostate cancer diagnosis. Clin Cancer Res 12 ( 1 ): 89-96.
13. Brown DA, Ward RL, Buckhaults P, Liu T, Romans KE, Hawkins NJ, Bauskin AR, Kinzler KW, Vogelstein B, Breit SN. 2003. MIC-1 serum level and genotype: associations with progress and prognosis of colorectal carcinoma. Clin Cancer Res 9 ( 7 ): 2642-2650.
14. Buckhaults P, Rago C, St Croix B, Romans KE, Saha S, Zhang L, Vogelstein B, Kinzler KW. 2001. Secreted and cell surface genes expressed in benign and malignant colorectal tumors. Cancer Res 61 ( 19 ): 6996-7001.
15. Fiedler K, Kellner R, Simons K. 1997. Mapping the protein composition of trans- Golgi network (TGN)-derived carrier vesicles from polarized MDCK cells. Electrophoresis 18(14):2613-2629.
16. Fairlie WD, Moore AG, Bauskin AR, Russell PK, Zhang HP, Breit SN. 1999. MIC-1 is a novel TGF-beta superfamily cytokine associated with macrophage activation. J Leukoc Biol 65 ( 1 ): 2-5.
17. Fairlie WD, Russell PK, Wu WM, Moore AG, Zhang HP, Brown PK, Bauskin AR, Breit SN. 2001a. Epitope mapping of the transforming growth factor-beta superfamily protein, macrophage inhibitory cytokine-1 (MIC-1): identifi cation of at least fi ve distinct epitope specifi cities. Biochemistry 40 ( 1 ): 65-73.
18. Fairlie WD, Zhang HP, Wu WM, Pankhurst SL, Bauskin AR, Russell PK, Brown PK, Breit SN. 2001b. The propeptide of the transforming growth factor-beta superfamily member, macrophage inhibitory cytokine-1 (MIC-1), is a multifunctional domain that can facilitate protein folding and secretion. J Biol Chem 276 ( 20 ): 16911-16918.
19. Ferrari N, Pfeffer U, Dell'Eva R, Ambrosini C, Noonan DM, Albini A. 2005. The transforming growth factor-beta family members bone morphogenetic protein-2 and macrophage inhibitory cytokine-1 as mediators of the antiangiogenic activity of N -(4-hydroxyphenyl)retinamide. Clin Cancer Res 11 ( 12 ): 4610-4619.
20. Gray AM, Mason AJ. 1990. Requirement for activin A and transforming growth factor-beta 1 pro-regions in homodimer assembly. Science 247 ( 4948 ): 1328-1330.
21. Grell M, Douni E, Wajant H, Löhden M, Clauss M, Maxeiner B, Georgopoulos S, Lesslauer W, Kollias G, Pfi zenmaier K, Scheurich P. 1995. The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor. Cell 83 ( 5 ): 793-802.
22. Hervouet E, Pecina P, Demont J, Vojtísková A, Simonnet H, Houstek J, Godinot C. 2006. Inhibition of cytochrome c oxidase subunit 4 precursor processing by the hypoxia mimic cobalt chloride. Biochem Biophys Res Commun 344 ( 4 ): 1086-1093.
23. Heymach JV, Jr., Krüttgen A, Suter U, Shooter EM. 1996. The regulated secretion and vectorial targeting of neurotrophins in neuroendocrine and epithelial cells. J Biol Chem 271 ( 41 ): 25430-25437.
24. Johnen H, Lin S, Kuffner T, Brown DA, Tsai VW, Bauskin AR, Wu L, Pankhurst G, Jiang L, Junankar S, Hunter M, Fairlie WD, Lee NJ, Enriquez RF, Baldock PA, Corey E, Apple FS, Murakami MM, Lin EJ, Wang C, During MJ, Sainsbury A, Herzog H, Breit SN. 2007. Tumor-induced anorexia and weight loss are mediated by the TGF-beta superfamily cytokine MIC-1. Nat Med 13 ( 11 ): 1333-1340.
25. Kannan K, Amariglio N, Rechavi G, Givol D. 2000. Profi le of gene expression regulated by induced p53: connection to the TGFbeta family. FEBS Lett 470 ( 1 ): 77-82.
26. Kempf T, von Haehling S, Peter T, Allhoff T, Cicoira M, Doehner W, Ponikowski P, Filippatos GS, Rozentryt P, Drexler H, Anker SD, Wollert KC. 2007. Prognostic utility of growth differentiation factor-15 in patients with chronic heart failure. J Am Coll Cardiol 50 ( 11 ): 1054-1060.
27. Knowles HJ, Harris AL. 2007. Macrophages and the hypoxic tumour microenvironment. Front Biosci 12: 4298-4314.
28. Koniaris LG. 2003. Induction of MIC-1/growth differentiation factor-15 following bile duct injury. J Gastrointest Surg 7 ( 7 ): 901-905.
29. Koopmann J, Buckhaults P, Brown DA, Zahurak ML, Sato N, Fukushima N, Sokoll LJ, Chan DW, Yeo CJ, Hruban RH, Breit SN, Kinzler KW, Vogelstein B, Goggins M. 2004. Serum macrophage inhibitory cytokine 1 as a marker of pancreatic and other periampullary cancers. Clin Cancer Res 10 ( 7 ): 2386-2392.
30. Kreitzer G, Marmorstein A, Okamoto P, Vallee R, Rodriguez-Boulan E. 2000. Kinesin and dynamin are required for post-Golgi transport of a plasma- membrane protein. Nat Cell Biol. 2(2):125-127.
31. Li PX, Wong J, Ayed A, Ngo D, Brade AM, Arrowsmith C, Austin RC, Klamut HJ. 2000. Placental transforming growth factor-beta is a downstream mediator of the growth arrest and apoptotic response of tumor cells to DNA damage and p53 overexpression. J Biol Chem 275 ( 26 ): 20127-20135.
32. Lippincott-Schwartz J, Donaldson JG, Schweizer A, Berger EG, Hauri HP, Yuan LC, Klausner RD. 1990. Microtubule-dependent retrograde transport of proteins into the ER in the presence of brefeldin A suggests an ER recycling pathway. Cell 60 ( 5 ): 821-836.
33. Liu FQ, Liu Y, Lui VC, Lamb JR, Tam PK, Chen Y. 2008. Hypoxia modulates lipopolysaccharide induced TNF-alpha expression in murine macrophages. Exp Cell Res 314 ( 6 ): 1327-1336.
34. Manderson AP, Kay JG, Hammond LA, Brown DL, Stow JL. 2007. Subcompartments of the macrophage recycling endosome direct the differential secretion of IL-6 and TNFalpha. J Cell Biol 178 ( 1 ): 57-69.
35. Muller L, Barret A, Picart R, Tougard C. 1997. Proteolytic processing of sulfated secretogranin II in the trans-Golgi network of GH3B6 prolactin cells. J Biol Chem 272 ( 6 ): 3669-3673.
36. Murdoch C, Muthana M, Lewis CE. 2005. Hypoxia regulates macrophage functions in infl ammation. J Immunol 175 ( 10 ): 6257-6263.
37. Murray RZ, Kay JG, Sangermani DG, Stow JL. 2005a. A role for the phagosome in cytokine secretion. Science 310 ( 5753 ): 1492-1495.
38. Murray RZ, Wylie FG, Khromykh T, Hume DA, Stow JL. 2005b. Syntaxin 6 and Vti1b form a novel SNARE complex, which is up-regulated in activated macrophages to facilitate exocytosis of tumor necrosis Factor-alpha. J Biol Chem 280 ( 11 ): 10478-10483.
39. Nakai A, Kawatani T, Ohi S, Kawasaki H, Yoshimori T, Tashiro Y, Miyata Y, Yahara I, Satoh M, Nagata K. 1995. Expression and phosphorylation of BiP/GRP78, a molecular chaperone in the endoplasmic reticulum, during the differentiation of a mouse myeloblastic cell line. Cell Struct Funct 20 ( 1 ): 33-39.
40. Nickel W. 2003. The mystery of nonclassical protein secretion. A current view on cargo proteins and potential export routes. Eur J Biochem 270 ( 10 ): 2109-2119.
41. Pagan JK, Wylie FG, Joseph S, Widberg C, Bryant NJ, James DE, Stow JL. 2003. The t-SNARE syntaxin 4 is regulated during macrophage activation to function in membrane traffi c and cytokine secretion. Curr Biol 13 ( 2 ): 156-160.
42. Ponnambalam S, Baldwin SA. 2003. Constitutive protein secretion from the trans-Golgi network to the plasma membrane. Mol Membr Biol 20 ( 2 ): 129-139.
43. Scheiffele P, Peränen J, Simons K. 1995. N-glycans as apical sorting signals in epithelial cells. Nature 378(6552):96-98.
44. Salnikow K, Donald SP, Bruick RK, Zhitkovich A, Phang JM, Kasprzak KS. 2004. Depletion of intracellular ascorbate by the carcinogenic metals nickel and cobalt results in the induction of hypoxic stress. J Biol Chem 279 ( 39 ): 40337-40344.
45. Schlittenhardt D, Schober A, Strelau J, Bonaterra GA, Schmiedt W, Unsicker K, Metz J, Kinscherf R. 2004. Involvement of growth differentiation factor-15/macrophage inhibitory cytokine-1 (GDF-15/MIC-1) in oxLDL-induced apoptosis of human macrophages in vitro and in arteriosclerotic lesions. Cell Tissue Res 318 ( 2 ): 325-333.
46. Schober A, Böttner M, Strelau J, Kinscherf R, Bonaterra GA, Barth M, Schilling L, Fairlie WD, Breit SN, Unsicker K. 2001. Expression of growth differentiation factor-15/ macrophage inhibitory cytokine-1 (GDF-15/MIC-1) in the perinatal, adult, and injured rat brain. J Comp Neurol 439 ( 1 ): 32-45.
47. Seidah NG, Prat A. 2002. Precursor convertases in the secretory pathway, cytosol and extracellular milieu. Essays Biochem 38: 79-94.
48. Shurety W, Merino-Trigo A, Brown D, Hume DA, Stow JL. 2000. Localization and post-Golgi traffi cking of tumor necrosis factoralpha in macrophages. J Interferon Cytokine Res 20 ( 4 ): 427-438.
49. Stawowy P, Meyborg H, Stibenz D, Borges Pereira Stawowy N, Roser M, Thanabalasingam U, Veinot JP, Chrétien M, Seidah NG, Fleck E, Graf K. 2005. Furin-like proprotein convertases are central regulators of the membrane type matrix metalloproteinase-promatrix metalloproteinase-2 proteolytic cascade in atherosclerosis. Circulation 111 ( 21 ): 2820-2827.
50. Strelau J, Böttner M, Lingor P, Suter-Crazzolara C, Galter D, Jaszai J, Sullivan A, Schober A, Krieglstein K, Unsicker K. 2000. GDF-15/ MIC-1 a novel member of the TGF-beta superfamily. J Neural Transm Suppl. 60:273-276.
51. Suter U, Heymach JV, Jr., Shooter EM. 1991. Two conserved domains in the NGF propeptide are necessary and suffi cient for the biosynthesis of correctly processed and biologically active NGF. EMBO J 10 ( 9 ): 2395-2400.
52. Tan M, Wang Y, Guan K, Sun Y. 2000. PTGF-beta, a type beta transforming growth factor (TGF-beta) superfamily member, is a p53 target gene that inhibits tumor cell growth via TGF-beta signaling pathway. Proc Natl Acad Sci USA 97 ( 1 ): 109-114.
53. Taylor NA, Van De Ven WJ, Creemers JW. 2003. Curbing activation: proprotein convertases in homeostasis and pathology. FASEB J 17 ( 10 ): 1215-1227.
54. Welsh JB, Sapinoso LM, Kern SG, Brown DA, Liu T, Bauskin AR, Ward RL, Hawkins NJ, Quinn DI, Russell PJ, Sutherland RL, Breit SN, Moskaluk CA, Frierson HF, Jr., Hampton GM. 2003. Large-scale delineation of secreted protein biomarkers overexpressed in cancer tissue and serum. Proc Natl Acad Sci USA 100 ( 6 ): 3410-3415.
55. Welsh JB, Sapinoso LM, Su AI, Kern SG, Wang-Rodriguez J, Moskaluk CA, Frierson HF, Jr., Hampton GM. 2001. Analysis of gene expression identifi es candidate markers and pharmacological targets in prostate cancer. Cancer Res 61 ( 16 ): 5974-5978.
56. Wise RJ, Pittman DD, Handin RI, Kaufman RJ, Orkin SH. 1988. The propeptide of von Willebrand factor independently mediates the assembly of von Willebrand multimers. Cell 52 ( 2 ): 229-236.
57. Yang H, Filipovic Z, Brown D, Breit SN, Vassilev LT. 2003. Macrophage inhibitory cytokine-1: a novel biomarker for p53 pathway activation. Mol Cancer Ther 2 ( 10 ): 1023-1029.
58. Yuan A, Chen JJ, Yang PC. 2008. Pathophysiology of tumor-associated macrophages. Adv Clin Chem 45: 199-223.